Elevance Health Inc. (ELV) Tops Q3 EPS by 54c; updates Guidance

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.99, $0.54 better than the analyst estimate of $8.45. Revenue for the quarter came in at $42.48 billion versus the consensus estimate of $42.76 billion.

GUIDANCE:

Elevance Health Inc. sees FY2023 adjusted EPS to be greater than $33.00, versus the consensus of $32.93.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apple’s big price hike seen as "an unprecedented push to protect margins"
• Investing.com’s stocks of the week